Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Seletracetam in Epilepsy
NCT00175851Phase 3Withdrawn
- Sponsor
- UCB
- Start
- May 2008
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of seletracetam in epilepsy, sponsored by UCB. Primary endpoint: Safety profile of seletracetam. Planned start May 2008; status: withdrawn.
02
Drugs
seletracetam
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00175851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00175851.